Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non–Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy
At a tertiary care center, the rate of surgical intervention after neoadjuvant chemoimmunotherapy was 58%. These results require further validation in additional external cohorts and highlight the need for optimal patient selection to ensure the use of curative surgery.
Authors
- William P. Levin
- Michelle Iocolano (ORCID: https://orcid.org/0000-0002-6125-0754)
- Taine Pechet
- Melina E. Marmarelis (ORCID: https://orcid.org/0000-0003-2187-3583)
- Christiana Davis
- Steven J. Feigenberg (ORCID: https://orcid.org/0000-0001-6179-0040)
- Christopher D’Avella (ORCID: https://orcid.org/0000-0003-2276-0257)
- Cole Friedes (ORCID: https://orcid.org/0000-0003-4941-889X)
- Charu Aggarwal (ORCID: https://orcid.org/0000-0002-3181-9460)
- John C. Kucharczuk (ORCID: https://orcid.org/0000-0001-6629-1486)
- Keith A. Cengel (ORCID: https://orcid.org/0000-0001-6960-5882)
- Nikhil Yegya‐Raman (ORCID: https://orcid.org/0000-0003-4946-2348)
- Christine Ciunci (ORCID: https://orcid.org/0000-0001-8056-7784)
- Corey J. Langer (ORCID: https://orcid.org/0000-0002-8483-6811)
- Aditi Singh (ORCID: https://orcid.org/0000-0001-7438-2863)
- J.D. Bradley
- Roger B. Cohen
Institutions
- Thoracic Surgery Foundation (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1097/coc.0000000000001260
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00